Trade & Channel Strategies 2024: Boosting Patient Support & Engagement Across Care Settings

PC: Back in August, you penned an article on "Enhancing Patient Access and Support Through Technology: A Comprehensive Assessment." What was the premise of the piece, and why exactly do you believe the integration of AI-enabled solutions has the potential to boost patient support and engagement across numerous patient care settings?

Allen: The impetus for my partner, John Hamrick, and I to delve into this was what we saw from our pharmaceutical manufacturer clients. It’s really the need to really reach into the technology support and leverage that to make an impact on patient engagement. We sought to outline an understanding of where we are from an ecosystem perspective in those tools, and then to outline best practices in vetting these different types of solutions and then how we would go about implementing those. So, I’d say the outcomes have been very positive. Manufacturers are eager to look at ways to optimize the patient journey with technology support solutions. So, we’re very excited about next steps in that area.

PC: What industry challenges are at the forefront for Curatio, and how might those change heading into 2025?

Allen: I think back about the article, and you know, as I said, the impetus for moving forward with this, we look at the desire for manufacturers to really reach out and to provide solutions for patients. We see the Lilly team coming forward with LillyDirect for those three big areas that they have. We also see Pfizer moving forward with some similar offerings. From a trends perspective, we do see pharmaceutical manufacturers looking to leverage these tools to optimize the patient journey.